| Literature DB >> 32199587 |
Milos Kostic1, Nikola Zivkovic2, Ana Cvetanovic3, Goran Marjanović4.
Abstract
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts due to enhanced platelet clearance and compromised production. Traditionally, ITP was regarded a B cell mediated disorder as anti-platelet antibodies are detected in most patients. The very nature of self-antigens, evident processes of isotype switching and the affinity maturation of anti-platelet antibodies indicate that B cells in order to mount anti-platelet immune response require assistance of auto-reactive CD4+ T cells. For a long time, ITP pathogenesis has been exclusively reviewed through the prism of the disturbed balance between Th1 and Th2 subsets of CD4+ T cells, however, more recently new subsets of these cells have been described including Th17, Th9, Th22, T follicular helper and regulatory T cells. In this paper, we review the current understanding of the role and immunological mechanisms by which CD4+ T cells contribute to the pathogenesis of ITP.Entities:
Keywords: Immune thrombocytopenia; Platelet; Tfh cell; Th1 cell; Th17 cell; Th2 cell; Th22 cell; Th9 cell; Treg
Year: 2020 PMID: 32199587 DOI: 10.1016/j.cellimm.2020.104096
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.868